Arcturus Therapeutics Holdings Inc (ARCT) Q3 2024 Earnings Call Highlights:...

Published on 8 Nov 2024 on GuruFocus.com · via Yahoo Finance

Revenue: $41.7 million for Q3 2024, down from $45.1 million in Q3 2023. Operating Expenses: $52.4...

Read the rest of the article

Start tracking your investments with Statfolio

Revenue: $41.7 million for Q3 2024, down from $45.1 million in Q3 2023. Operating Expenses: $52.4...

GuruFocus.com · via Yahoo Finance 8 Nov 2024

Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) is set to release its Q3 2024 earnings on Nov 7,...

GuruFocus.com · via Yahoo Finance 6 Nov 2024

We recently compiled a list of the 10 Worst ARK Stocks To Buy According To Short Sellers. In this...

Insider Monkey · via Yahoo Finance 24 Aug 2024

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q1 2024 Earnings Call Transcript May 8, 2024 Ar...

Insider Monkey via Yahoo Finance 9 May 2024

It might be of some concern to shareholders to see the Arcturus Therapeutics Holdings Inc. (NASDA...

Simply Wall St. via Yahoo Finance 29 Apr 2024

Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT), a biotechnology company focused on the discover...

GuruFocus.com via Yahoo Finance 28 Mar 2024

Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT), a biotechnology company focused on the discover...

GuruFocus.com via Yahoo Finance 22 Mar 2024

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2023 Earnings Call Transcript March 7, 2024 ...

Insider Monkey via Yahoo Finance 8 Mar 2024

Shares of Arcturus Therapeutics Holdings Inc. ARCT have surged 73% in the past three months compa...

Zacks via Yahoo Finance 4 Mar 2024

Key Insights The projected fair value for Arcturus Therapeutics Holdings is US$47.95 based on 2 S...

Simply Wall St. via Yahoo Finance 22 Dec 2023